|
COG6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.25139948087872E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.39180000857664E-09 |
| Normal-vs-Stage2 |
1.122340E-03 |
| Normal-vs-Stage3 |
3.244000E-04 |
| Normal-vs-Stage4 |
1.160440E-03 |
| Stage1-vs-Stage2 |
6.965400E-01 |
| Stage1-vs-Stage3 |
6.299400E-01 |
| Stage1-vs-Stage4 |
7.360400E-01 |
| Stage2-vs-Stage3 |
9.774200E-01 |
| Stage2-vs-Stage4 |
9.594400E-01 |
| Stage3-vs-Stage4 |
9.774600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.4290004169435E-10 |
| Normal-vs-AfricanAmerican |
8.05830000000229E-05 |
| Normal-vs-Asian |
6.736100E-02 |
| Caucasian-vs-AfricanAmerican |
3.164600E-01 |
| Caucasian-vs-Asian |
8.708200E-01 |
| AfricanAmerican-vs-Asian |
6.348800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.65339972216339E-11 |
| Normal-vs-Female |
1.880870E-03 |
| Male-vs-Female |
1.206200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.97399999977289E-07 |
| Normal-vs-Extreme_Weight |
2.53209675449284E-11 |
| Normal-vs-Obese |
6.35369999999469E-05 |
| Normal-vs-Extreme_Obese |
9.945600E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.249400E-01 |
| Normal_Weight-vs-Obese |
2.234400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.078400E-01 |
| Extreme_Weight-vs-Obese |
3.002200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.678000E-01 |
| Obese-vs-Extreme_Obese |
9.790600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.180900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.19659999997523E-06 |
| Normal-vs-Age(61-80Yrs) |
1.47389989102464E-10 |
| Normal-vs-Age(81-100Yrs) |
2.56039999979585E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.712800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.398600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.731200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.282300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.535700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.119600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.34520189326781E-11 |
| Normal-VS-Type2 PRCC |
2.38669999998997E-05 |
| Normal-VS-KIRP CIMP |
1.732110E-02 |
| Normal-VS-Unclassified PRCC |
1.191610E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.870000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.218200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.698400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.903600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.516000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.679400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.84450004953641E-09 |
| Normal-vs-N1 |
7.103800E-03 |
| Normal-vs-N2 |
9.43960000054922E-07 |
| N0-vs-N1 |
9.708300E-02 |
| N0-vs-N2 |
1.411950E-01 |
| N1-vs-N2 |
4.243500E-02 |
|
|
